Aroa Biosurgery Ltd (ARX) - Total Liabilities
Based on the latest financial reports, Aroa Biosurgery Ltd (ARX) has total liabilities worth AU$14.34 Million AUD (≈ $10.15 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Aroa Biosurgery Ltd - Total Liabilities Trend (2001–2025)
This chart illustrates how Aroa Biosurgery Ltd's total liabilities have evolved over time, based on quarterly financial data. See working capital position of Aroa Biosurgery Ltd to evaluate short-term liquidity relative to the company's equity base.
Aroa Biosurgery Ltd Competitors by Total Liabilities
The table below lists competitors of Aroa Biosurgery Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Auna S.A.
NYSE:AUNA
|
USA | $5.53 Billion |
|
Seoul Broadcasting System
KO:034120
|
Korea | ₩686.54 Billion |
|
Omaxe Limited
NSE:OMAXE
|
India | Rs174.15 Billion |
|
Long Bon International Co Ltd
TW:2514
|
Taiwan | NT$17.47 Billion |
|
cBrain A/S
CO:CBRAIN
|
Denmark | Dkr120.83 Million |
|
Trabzonspor Sportif Yatirim ve Futbol Isletmeciligi Ticaret AS
IS:TSPOR
|
Turkey | TL6.12 Billion |
|
Zhejiang Zone King Environmental Sci&Tech Co Ltd
SHG:688701
|
China | CN¥317.25 Million |
|
Niu Technologies
F:0O9
|
Germany | €2.05 Billion |
Liability Composition Analysis (2001–2025)
This chart breaks down Aroa Biosurgery Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see ARX market cap overview.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 6.52 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.18 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.15 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Aroa Biosurgery Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Aroa Biosurgery Ltd (2001–2025)
The table below shows the annual total liabilities of Aroa Biosurgery Ltd from 2001 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | AU$14.35 Million ≈ $10.15 Million |
-2.98% |
| 2024-03-31 | AU$14.79 Million ≈ $10.46 Million |
+7.97% |
| 2023-03-31 | AU$13.69 Million ≈ $9.69 Million |
+21.15% |
| 2022-03-31 | AU$11.30 Million ≈ $8.00 Million |
-41.83% |
| 2021-03-31 | AU$19.43 Million ≈ $13.75 Million |
-1.24% |
| 2020-03-31 | AU$19.68 Million ≈ $13.92 Million |
-25.58% |
| 2019-03-31 | AU$26.44 Million ≈ $18.71 Million |
+110.93% |
| 2018-03-31 | AU$12.53 Million ≈ $8.87 Million |
+5241.03% |
| 2017-03-31 | AU$234.69K ≈ $166.06K |
-47.09% |
| 2016-03-31 | AU$443.57K ≈ $313.85K |
-24.31% |
| 2015-03-31 | AU$586.00K ≈ $414.63K |
-29.14% |
| 2014-03-31 | AU$827.00K ≈ $585.16K |
+132.96% |
| 2013-03-31 | AU$355.00K ≈ $251.19K |
-77.64% |
| 2012-03-31 | AU$1.59 Million ≈ $1.12 Million |
-52.15% |
| 2011-03-31 | AU$3.32 Million ≈ $2.35 Million |
-3.91% |
| 2010-03-31 | AU$3.45 Million ≈ $2.44 Million |
-96.73% |
| 2009-03-31 | AU$105.73 Million ≈ $74.81 Million |
+17.85% |
| 2008-03-31 | AU$89.72 Million ≈ $63.48 Million |
+54.09% |
| 2007-03-31 | AU$58.23 Million ≈ $41.20 Million |
+626.10% |
| 2006-03-31 | AU$8.02 Million ≈ $5.67 Million |
+83.38% |
| 2005-03-31 | AU$4.37 Million ≈ $3.09 Million |
+69.23% |
| 2004-03-31 | AU$2.58 Million ≈ $1.83 Million |
+9.96% |
| 2003-03-31 | AU$2.35 Million ≈ $1.66 Million |
+6.67% |
| 2002-03-31 | AU$2.20 Million ≈ $1.56 Million |
-81.71% |
| 2001-03-31 | AU$12.04 Million ≈ $8.52 Million |
-- |
About Aroa Biosurgery Ltd
Aroa Biosurgery Limited develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally. Its products include Endoform Natural and Endoform Antimicrobial Restorative Bioscaffold for treating acute and chronic wounds; Myriad Matrix, an engineered ECM for soft tissue repair, reinforcement, and co… Read more